Puma Biotechnology Inc logo

Puma Biotechnology Inc

$ 4.26 -0.47 (-9.94%) 10:08 PM EST
P/E:
19.36
P/B:
8.69
Market Cap:
$ 194.43M
Enterprise V:
$ 252.82M
Volume:
393.57K
Avg Vol (2M):
242.02K
Also Trade In:
Volume:
393.57K
Market Cap $:
194.43M
PE Ratio:
19.36
Avg Vol (2-Month):
242.02K
Enterprise Value $:
252.82M
PB Ratio:
8.69
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Puma Biotechnology Inc is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. The company in-licenses the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357. Neratinib, oral was approved by the U.S. FDA in 2017 for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer, following adjuvant trastuzumab-based therapy, and is marketed in the US as NERLYNX.
Name Current Vs Industry Vs History
Cash-To-Debt 0.68
Equity-to-Asset 0.11
Debt-to-Equity 5.19
Debt-to-EBITDA 3.8
Interest Coverage 2.5
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -7.03
Distress
Grey
Safe
Beneish M-Score -0.97
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 60.4
9-Day RSI 65.67
14-Day RSI 66.47
6-1 Month Momentum % 15.71
12-1 Month Momentum % -36.49

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.04
Quick Ratio 1.95
Cash Ratio 1.3
Days Inventory 49.07
Days Sales Outstanding 48.75
Days Payable 92.28

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.4

Financials (Next Earnings Date:2023-03-03 Est.)

PBYI's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PBYI

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 217.713
EPS (TTM) ($) 0.22
Beta 0.46
Volatility % 77.08
14-Day RSI 66.47
14-Day ATR ($) 0.349125
20-Day SMA ($) 3.238
12-1 Month Momentum % -36.49
52-Week Range ($) 1.6 - 4.81
Shares Outstanding (Mil) 45.64

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Puma Biotechnology Inc Filings

Document Form Filing Date
No Filing Data

Puma Biotechnology Inc Analysis

Share your research

Headlines

See More
No news.